公司資料
IQVIA 股價、新聞與催化劑
- 股票代碼:
- IQV
- 交易所:
- NYSE
- 產業:
- Biopharma
- 所在地:
- United States
股票表現
241.24 USD (+1.94%)
收盤價
最後更新: 2026年8月17日
30.1B USD
市值
股價為何變動
As of Aug 17, 2026, IQV closed up 1.94% at $241.24. No new same-company headline was identified in the current news window.
公司概覽
業務概覽
IQVIA is a healthcare data, analytics, and contract research company that supports pharmaceutical development and commercialization. It is a critical infrastructure name for the drug-development ecosystem rather than a therapeutic developer.
所在地與產業分類
Headquartered in the United States and listed on NYSE, IQVIA has a global footprint across clinical, commercial, and real-world data services. It sits in healthcare services and research infrastructure.
商業模式特徵
The company earns revenue from contract research, data analytics, technology-enabled services, and life sciences consulting. Investors focus on clinical demand, services growth, and the health of biopharma R&D budgets.
生技產業定位
IQVIA sits inside the biotech ecosystem as a services and data platform. It is not binary like a drug stock, but it is highly relevant because it benefits from and helps enable drug development activity.
未來催化劑
- IQVIA’s key catalyst is still clinical-outsourcing demand, with bookings, backlog conversion, and AI-enabled service productivity doing most of the work. That readout matters because it decides whether the asset is ready for a larger and more expensive development step. If the data come in cleanly, the market tends to give the broader platform behind the program more credit.
近期新聞
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。